EdgarLookup

LINCOLN NATIONAL CORP — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that LINCOLN NATIONAL CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
6.5%
Profit Margin
Net income ÷ revenue
0.3%
Return on Assets
Net income ÷ assets
37.25x
Debt-to-Equity
Total liabilities ÷ equity
-1.2%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $18.21B Feb 19, 2026
FY2025 Dec 31, 2024 $18.44B Feb 19, 2026
FY2025 Dec 31, 2023 $11.65B Feb 19, 2026
FY2022 Dec 31, 2022 $4.22B Mar 30, 2023
FY2022 Sep 30, 2022 $4.78B Mar 30, 2023
FY2022 Jun 30, 2022 $5.09B Mar 30, 2023
FY2022 Mar 31, 2022 $4.67B Mar 30, 2023
FY2022 Dec 31, 2021 $5.23B Mar 30, 2023
FY2022 Sep 30, 2021 $5.24B Mar 30, 2023
FY2022 Jun 30, 2021 $4.86B Mar 30, 2023

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2018 Dec 31, 2018 $1.34B Feb 20, 2019

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.18B Feb 19, 2026
FY2025 Dec 31, 2024 $3.28B Feb 19, 2026
FY2025 Dec 31, 2023 ($752.00M) Feb 19, 2026
FY2022 Dec 31, 2022 $21.00M Mar 30, 2023
FY2022 Sep 30, 2022 ($2.58B) Mar 30, 2023
FY2022 Jun 30, 2022 $228.00M Mar 30, 2023
FY2022 Mar 31, 2022 $92.00M Mar 30, 2023
FY2022 Dec 31, 2021 $708.00M Mar 30, 2023
FY2022 Sep 30, 2021 $316.00M Mar 30, 2023
FY2022 Jun 30, 2021 $645.00M Mar 30, 2023

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($167.00M) Feb 19, 2026
FY2025 Dec 31, 2024 ($2.01B) Feb 19, 2026
FY2025 Dec 31, 2023 ($2.07B) Feb 19, 2026
FY2024 Dec 31, 2022 $3.61B Feb 21, 2025
FY2022 Sep 30, 2022 $3.39B Mar 30, 2023
FY2022 Jun 30, 2022 $2.71B Mar 30, 2023
FY2022 Mar 31, 2022 $752.00M Mar 30, 2023
FY2023 Dec 31, 2021 ($217.00M) Feb 22, 2024
FY2022 Sep 30, 2021 $125.00M Mar 30, 2023
FY2022 Jun 30, 2021 ($213.00M) Mar 30, 2023

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $417.20B Feb 19, 2026
FY2025 Dec 31, 2024 $390.83B Feb 19, 2026
FY2024 Dec 31, 2023 $372.41B Feb 21, 2025
FY2023 Dec 31, 2022 $334.33B Feb 22, 2024
FY2022 Sep 30, 2022 $324.17B Mar 30, 2023
FY2022 Jun 30, 2022 $335.35B Mar 30, 2023
FY2022 Mar 31, 2022 $365.54B Mar 30, 2023
FY2022 Dec 31, 2021 $386.95B Mar 30, 2023
FY2022 Sep 30, 2021 $376.90B Mar 30, 2023
FY2022 Jun 30, 2021 $379.88B Mar 30, 2023

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $406.30B Feb 19, 2026
FY2025 Dec 31, 2024 $382.56B Feb 19, 2026
FY2024 Dec 31, 2023 $365.52B Feb 21, 2025
FY2023 Dec 31, 2022 $329.23B Feb 22, 2024
FY2022 Sep 30, 2022 $321.51B Mar 30, 2023
FY2022 Jun 30, 2022 $325.69B Mar 30, 2023
FY2022 Mar 31, 2022 $350.35B Mar 30, 2023
FY2022 Dec 31, 2021 $366.19B Mar 30, 2023
FY2022 Sep 30, 2021 $355.73B Mar 30, 2023
FY2022 Jun 30, 2021 $358.14B Mar 30, 2023

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $10.91B Feb 19, 2026
FY2025 Dec 31, 2024 $8.27B Feb 19, 2026
FY2025 Dec 31, 2023 $6.89B Feb 19, 2026
FY2024 Dec 31, 2022 $5.10B Feb 21, 2025
FY2022 Sep 30, 2022 $2.67B Mar 30, 2023
FY2022 Jun 30, 2022 $9.65B Mar 30, 2023
FY2022 Mar 31, 2022 $15.18B Mar 30, 2023
FY2023 Dec 31, 2021 $19.92B Feb 22, 2024
FY2022 Sep 30, 2021 $21.17B Mar 30, 2023
FY2022 Jun 30, 2021 $21.74B Mar 30, 2023

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.14B Feb 19, 2026
FY2025 Dec 31, 2024 $1.14B Feb 19, 2026
FY2025 Dec 31, 2023 $1.14B Feb 19, 2026
FY2024 Dec 31, 2022 $1.14B Feb 21, 2025
FY2022 Sep 30, 2022 $1.14B Mar 30, 2023
FY2022 Jun 30, 2022 $1.78B Mar 30, 2023
FY2022 Mar 31, 2022 $1.78B Mar 30, 2023
FY2023 Dec 31, 2021 $1.78B Feb 22, 2024
FY2022 Sep 30, 2021 $1.78B Mar 30, 2023
FY2022 Jun 30, 2021 $1.78B Mar 30, 2023

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $8.39B Feb 19, 2026
FY2025 Dec 31, 2024 $7.65B Feb 19, 2026
FY2024 Dec 31, 2023 $4.78B Feb 21, 2025
FY2023 Dec 31, 2022 $5.92B Feb 22, 2024
FY2022 Sep 30, 2022 $6.76B Mar 30, 2023
FY2022 Jun 30, 2022 $9.45B Mar 30, 2023
FY2022 Mar 31, 2022 $9.35B Mar 30, 2023
FY2022 Dec 31, 2021 $9.58B Mar 30, 2023
FY2022 Sep 30, 2021 $9.36B Mar 30, 2023
FY2022 Jun 30, 2021 $9.24B Mar 30, 2023

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2017 Dec 31, 2017 $1.63B Feb 22, 2018
FY2017 Dec 31, 2016 $2.72B Feb 22, 2018
FY2017 Dec 31, 2015 $3.15B Feb 22, 2018
FY2017 Dec 31, 2014 $3.92B Feb 22, 2018
FY2016 Dec 31, 2013 $2.36B Feb 23, 2017
FY2015 Dec 31, 2012 $4.23B Feb 25, 2016
FY2014 Dec 31, 2011 $4.51B Feb 26, 2015
FY2013 Dec 31, 2010 $2.74B Feb 25, 2014
FY2010 Dec 31, 2009 $4.03B Feb 25, 2011
FY2009 Dec 31, 2008 $5.59B Feb 25, 2010

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $6.26B Feb 19, 2026
FY2024 Dec 31, 2024 $6.08B Feb 21, 2025
FY2023 Dec 31, 2023 $5.83B Feb 22, 2024
FY2022 Dec 31, 2022 $6.33B Mar 30, 2023
FY2021 Dec 31, 2021 $6.33B Feb 17, 2022
FY2020 Dec 31, 2020 $6.33B Feb 18, 2021
FY2019 Dec 31, 2019 $6.13B Feb 20, 2020
FY2018 Dec 31, 2018 $5.69B Feb 20, 2019
FY2017 Dec 31, 2017 $5.12B Feb 22, 2018
FY2016 Dec 31, 2016 $5.12B Feb 23, 2017

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 5 Feb 19, 2026
FY2025 Dec 31, 2024 18 Feb 19, 2026
FY2025 Dec 31, 2023 (4) Feb 19, 2026
FY2022 Dec 31, 2022 0 Mar 30, 2023
FY2022 Sep 30, 2022 (15) Mar 30, 2023
FY2022 Jun 30, 2022 1 Mar 30, 2023
FY2022 Mar 31, 2022 0 Mar 30, 2023
FY2022 Dec 31, 2021 3 Mar 30, 2023
FY2022 Sep 30, 2021 1 Mar 30, 2023
FY2022 Jun 30, 2021 3 Mar 30, 2023

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 5 Feb 19, 2026
FY2025 Dec 31, 2024 18 Feb 19, 2026
FY2025 Dec 31, 2023 (4) Feb 19, 2026
FY2022 Dec 31, 2022 0 Mar 30, 2023
FY2022 Sep 30, 2022 (15) Mar 30, 2023
FY2022 Jun 30, 2022 1 Mar 30, 2023
FY2022 Mar 31, 2022 0 Mar 30, 2023
FY2022 Dec 31, 2021 3 Mar 30, 2023
FY2022 Sep 30, 2021 1 Mar 30, 2023
FY2022 Jun 30, 2021 3 Mar 30, 2023

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 190.05M Feb 19, 2026
FY2025 Dec 31, 2024 170.38M Feb 19, 2026
FY2025 Dec 31, 2023 169.67M Feb 19, 2026
FY2025 Dec 31, 2022 169.22M Feb 19, 2026
FY2022 Sep 30, 2022 169.21M Mar 30, 2023
FY2022 Jun 30, 2022 170.22M Mar 30, 2023
FY2022 Mar 31, 2022 171.89M Mar 30, 2023
FY2024 Dec 31, 2021 177.19M Feb 21, 2025
FY2022 Sep 30, 2021 186.09M Mar 30, 2023
FY2022 Jun 30, 2021 189.09M Mar 30, 2023

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $325.00M Feb 19, 2026
FY2025 Dec 31, 2024 $307.00M Feb 19, 2026
FY2025 Dec 31, 2023 $305.00M Feb 19, 2026
FY2024 Dec 31, 2022 $310.00M Feb 21, 2025
FY2023 Dec 31, 2021 $319.00M Feb 22, 2024